Omgeo Taps Leveroni to Head Derivatives Strategy

Ted Leveroni, executive director of derivatives strategy, Omgeo

Omgeo has appointed Ted Leveroni as executive director of derivatives strategy and external relations. Leveroni, who joins the Boston-based vendor from State Street, will help to develop strategies to expand Omgeo's derivatives presence, while helping clients to navigate the changing regulatory landscape. He will report to Clare Fraser, who is Omgeo's managing director of strategy.

At State Street Leveroni was responsible for overseeing the execution for the firm's global collateral services. He also served a stint as the head of North American business development for State Street's investment manager services business and managed the equity/listed options trading desk for BankBoston.

"It is never an easy decision to leave a great company after 10 fun and successful years," Leveroni tells BST. "However, when Omgeo presented me with this role, I saw it as a great opportunity to make an immediate, impactful contribution to an already successful and trusted company. This role will allow me to leverage my derivatives expertise in order to help to drive the direction and success of Omgeo in an area that is of increasing importance to our community and regulators alike."

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Once a blockchain cheerleader, Axoni changes its playbook

The fintech, whose origins can be traced back to the genesis of capital markets’ complicated flirtation with DLT, has largely ditched the tech as the foundation of its data synchronization offering, opting for more familiar territory.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here